Which drugs are known for potentially increasing potassium levels?

Which drugs are known for potentially increasing potassium levels?

• A. Ketanserin, Dexamethasone, Celecoxib
• B. ACE inhibitors, Potassium supplements, ARA
• C. Amiodarone, Amlodipine, Beta-blockers
• D. Calcium channel blockers, Statins, Insulin

Answer: (B)

Drugs that are known for potentially increasing potassium levels primarily include ACE inhibitors, potassium supplements, and aldosterone receptor antagonists (ARA). ACE inhibitors, such as lisinopril or ramipril, work by inhibiting the renin-angiotensin-aldosterone system, which can lead to decreased aldosterone levels. Aldosterone plays a crucial role in potassium excretion, so when its levels drop, potassium can accumulate in the bloodstream, leading to hyperkalemia. Potassium supplements, as the name suggests, are directly used to increase potassium levels in the body and can lead to significant elevation if not monitored closely. ARA, such as spironolactone or eplerenone, similarly promote potassium retention by antagonizing aldosterone, further contributing to elevated potassium levels in patients taking these medications, especially in those with compromised renal function. The other options include drugs that either do not have a significant impact on potassium levels or are used for different therapeutic effects.

Drugs that are known for potentially increasing potassium levels primarily include ACE inhibitors, potassium supplements, and aldosterone receptor antagonists (ARA). ACE inhibitors, such as lisinopril or ramipril, work by inhibiting the renin-angiotensin-aldosterone system, which can lead to decreased aldosterone levels. Aldosterone plays a crucial role in potassium excretion, so when its levels drop, potassium can accumulate in the bloodstream, leading to hyperkalemia.

Potassium supplements, as the name suggests, are directly used to increase potassium levels in the body and can lead to significant elevation if not monitored closely. ARA, such as spironolactone or eplerenone, similarly promote potassium retention by antagonizing aldosterone, further contributing to elevated potassium levels in patients taking these medications, especially in those with compromised renal function.

The other options include drugs that either do not have a significant impact on potassium levels or are used for different therapeutic effects.